Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.33 |
| ▸ | GABBR2 | O75899 | 2/20 | 0.32 |
| ▸ | GABBR1 | Q9UBS5 | 2/20 | 0.32 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15196196 | 1.00 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL277522 | 1.00 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL3622991 | 1.00 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL1264382 | 1.00 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| Hydrochloric Acid SCHEMBL6036912 | 0.97 | LMNA (0.65) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL16690503 | 0.92 | LMNA (0.65) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL3628005 | 0.89 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL20429908 | 0.89 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL3625210 | 0.89 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL5956941 | 0.89 | LMNA (0.54) | LMNABLMPTPN1MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088395-B2 | Phytol derived immunoadjuvants and their use in vaccine formulations | INDIANA STATE UNIVERSITY (US) | 2012-01-03 | — | — | US | claimed |
| US-20060292163-A1 | PHYTOL DERIVED IMMUNOADJUVANTS AND THEIR USE IN VACCINE FORMULATIONS | INDIANA STATE UNIVERSITY | 2006-12-28 | — | — | US | claimed |
| US-20050158329-A1 | Novel phytol derived immunoadjuvants and their use in vaccine formulations | GHOSH SWAPAN K (US) | 2005-07-21 | — | — | US | claimed |
| US-8088395-B2 | Phytol derived immunoadjuvants and their use in vaccine formulations | INDIANA STATE UNIVERSITY (US) | 2012-01-03 | — | — | US | disclosed |
| US-7485604-B2 | Lubricant composition and method for using and preparing thereof | FUJIFILM CORPORATION (JP) | 2009-02-03 | — | — | US | disclosed |
| US-20060292163-A1 | PHYTOL DERIVED IMMUNOADJUVANTS AND THEIR USE IN VACCINE FORMULATIONS | INDIANA STATE UNIVERSITY | 2006-12-28 | — | — | US | disclosed |
| US-7018960-B2 | Lubricant composition, method for using and preparing thereof and molecular complex compound used for the same | FUJI PHOTO FILM CO., LTD. (JP) | 2006-03-28 | — | — | US | disclosed |
| US-20050158329-A1 | Novel phytol derived immunoadjuvants and their use in vaccine formulations | GHOSH SWAPAN K (US) | 2005-07-21 | — | — | US | disclosed |
| US-20050014657-A1 | Lubricant composition and method for using and preparing thereof | FUJI PHOTO FILM CO., LTD. (JP) | 2005-01-20 | — | — | US | disclosed |
| US-20030096715-A1 | Lubricant composition, method for using and preparing thereof and molecular complex compound used for the same | FUJIFILM CORPORATION (JP) | 2003-05-22 | — | — | US | disclosed |
| US-6528460-B2 | Triazine based structure with wear resistance, extreme pressure and low friction properties for mechanical friction sliding members | FUJI PHOTO FILM CO., LTD. (JP) | 2003-03-04 | — | — | US | disclosed |
| EP-1266950-A1 | Lubricant composition containing a triazine molecular complex compound | FUJI PHOTO FILM CO., LTD. (JP) | 2002-12-18 | — | — | EP | disclosed |
| US-20020147117-A1 | Lubricant composition | FUJIFILM CORPORATION (JP) | 2002-10-10 | — | — | US | disclosed |
| EP-1164182-A1 | Lubricant composition | Fuji Photo Film Co., Ltd. (JP) | 2001-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050158329-A1 | Novel phytol derived immunoadjuvants and their use in vaccine formulations | CD47, TSG101, LY96 | LMNA 3976/4885BLM 1167/4885PTPN1 475/4885 |
| US-20060292163-A1 | PHYTOL DERIVED IMMUNOADJUVANTS AND THEIR USE IN VACCINE FORMULATIONS | CD47, LY96, CD4 | LMNA 3674/4885BLM 946/4885PTPN1 317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.